Next Article in Journal
Mammalian Introns: When the Junk Generates Molecular Diversity
Next Article in Special Issue
Whole Exome Sequencing for a Patient with Rubinstein-Taybi Syndrome Reveals de Novo Variants besides an Overt CREBBP Mutation
Previous Article in Journal
Assessing the Antimicrobial Activity of Polyisoprene Based Surfaces
Previous Article in Special Issue
The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review
Article

Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical Case Report

Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, Kansas 66160, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Kenji Hashimoto
Int. J. Mol. Sci. 2015, 16(3), 4416-4428; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms16034416
Received: 19 December 2014 / Revised: 11 February 2015 / Accepted: 12 February 2015 / Published: 20 February 2015
Advances made in genetic testing and tools applied to pharmacogenetics are increasingly being used to inform clinicians in fields such as oncology, hematology, diabetes (endocrinology), cardiology and expanding into psychiatry by examining the influences of genetics on drug efficacy and metabolism. We present a clinical case example of an adolescent male with anxiety, attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder who did not tolerate numerous medications and dosages over several years in attempts to manage his symptoms. Pharmacogenetics testing was performed and DNA results on this individual elucidated the potential pitfalls in medication use because of specific pharmacodynamic and pharmacokinetic differences specifically involving polymorphisms of genes in the cytochrome p450 enzyme system. Future studies and reports are needed to further illustrate and determine the type of individualized medicine approach required to treat individuals based on their specific gene patterns. Growing evidence supports this biological approach for standard of care in psychiatry. View Full-Text
Keywords: pharmacogenetics; cytochrome p450 enzymes; psychotropic medications; psychiatry; behavior; autism; clinical case pharmacogenetics; cytochrome p450 enzymes; psychotropic medications; psychiatry; behavior; autism; clinical case
Show Figures

Graphical abstract

MDPI and ACS Style

Smith, T.; Sharp, S.; Manzardo, A.M.; Butler, M.G. Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical Case Report. Int. J. Mol. Sci. 2015, 16, 4416-4428. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms16034416

AMA Style

Smith T, Sharp S, Manzardo AM, Butler MG. Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical Case Report. International Journal of Molecular Sciences. 2015; 16(3):4416-4428. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms16034416

Chicago/Turabian Style

Smith, Teri, Susan Sharp, Ann M. Manzardo, and Merlin G. Butler 2015. "Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical Case Report" International Journal of Molecular Sciences 16, no. 3: 4416-4428. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms16034416

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop